Completed PHASE4 INTERVENTIONAL 2-arm NCT02655939

Study to Assess the Efficacy and Safety of Reflex Plus™ in Osteoarthritis

Double Blind, Randomized, Multicentre, Placebo Controlled Study to Assess the Efficacy and Safety of Reflex Plus™ in Osteoarthritis

Sponsor: Fullife Healthcare Pvt Ltd

Conditions Osteoarthritis

Interventions Placebo Reflex Plus

Updated 6 times since 2017 Last updated: Mar 24, 2017 Started: Dec 31, 2015 Primary completion: Nov 30, 2016 Completion: Nov 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Osteoarthritis and is currently completed. Fullife Healthcare Pvt Ltd leads this study, which shows 6 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Apr 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Apr 2017 [monthly]

Recruiting PHASE4

First recorded

Dec 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fullife Healthcare Pvt Ltd
Vedic Lifesciences Pvt. Ltd.

Data source: Vedic Lifesciences Pvt. Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mumbai, India